tiprankstipranks
Trending News
More News >
ImmuneOnco Biopharmaceuticals (Shanghai) Inc Class H (HK:1541)
:1541
Hong Kong Market
Advertisement

ImmuneOnco Biopharmaceuticals (Shanghai) Inc Class H (1541) Cash flow

Compare
0 Followers

ImmuneOnco Biopharmaceuticals (Shanghai) Inc Class H Cash Flow

HK:1541's free cash flow for Q4 2024 was ¥0.00. For the 2024 fiscal year, HK:1541's free cash flow was decreased by ¥231.81M and operating cash flow was ¥0.00. See a summary of the company’s cash flow.
Cash Flow
Dec 24Dec 23Dec 22Dec 21
Operating Cash Flow
¥ -128.03M¥ -367.55M¥ -238.71M¥ -190.54M
Investing Cash Flow
¥ 37.95M¥ -294.85M¥ 49.00K¥ -108.72M
Financing Cash Flow
¥ 258.93M¥ 331.04M¥ 179.38M¥ 793.03M
End Cash Position
¥ 477.60M¥ 306.98M¥ 635.21M¥ 668.33M
Free Cash Flow
¥ -138.44M¥ -370.25M¥ -261.93M¥ -315.79M
Currency in CNY

ImmuneOnco Biopharmaceuticals (Shanghai) Inc Class H Cash Flow

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis